Jefferies Upgrades CVS to 'Buy' with Higher Price Target

Billionaire Kerr Neilson has acquired more than $290,715 in stock within CVS Health Corporation (NYSE:) CVS ), accounting for 0.02% of his investment portfolio, ensuring the company's inclusion in Kerr Neilson, a Wealthy Individual, Has Identified 10 Stocks With Significant Growth Opportunities .

A group of actuarial professionals and engineers analyzing information through a computer to determine the most effective reinsurance option for a customer.

On July 1, 2025, Jefferies raised its price estimate for CVS Health Corporation (NYSE:CVS) from $74 to $80. The analyst cited the company's cautious outlook for upcoming performance as well as anticipated growth in earnings per share. Although facing challenges within the industry, CVS continues to be among the top choices in the analyst's selection of major healthcare companies.

In the first quarter of 2025, CVS Health Corporation (NYSE:CVS) recorded revenues of $95 billion, reflecting a 7% year-over-year growth. Additionally, its adjusted earnings per share reached $2.25 per share, with adjusted net income amounting to $4.6 billion. According to the firm's annual forecast, EPS is projected to fall between $6 and $6.2.

CVS Health Corporation (NYSE:CVS) provides health insurance, prescription drug administration (PBM), and retail pharmacy solutions. These offerings are delivered via its Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness divisions.

Although we recognize the growth possibilities of CVS, we remain confident that certain AI stocks offer better prospects for achieving superior returns with lower risks. If you're seeking an AI stock that surpasses CVS and offers up to 100 times the potential gain, review our analysis on this topic. cheapest AI stock.

READ NEXT: Top 7 Stocks That Offer Fast Gains and Top 10 Affordable Stocks Recommended by Billionaire Ray Dalio

Disclosure: None.